Target intelligence / Profile preview

KCNQ5 divergent transcript (KCNQ5-DT)

Target
KCNQ5-DT
Molecular classification
lncRNA, Long non-coding RNA
01

Overview

KCNQ5 divergent transcript (KCNQ5-DT) is a human long non-coding RNA (lncRNA) gene located in proximity to the protein-coding KCNQ5 gene. Unlike KCNQ5, which encodes the voltage-gated potassium channel subunit Kv7.5, KCNQ5-DT does not encode a protein. Its biological function remains undetermined, and there are no reported mechanisms, biomarkers, or therapeutic associations. KCNQ5-DT has been implicated in some genetic association studies as being near loci relevant to autosomal dominant intellectual disability, but there is no evidence that it is a therapeutic target, disease biomarker, or drug interaction partner[2][3][4][5]. The protein-coding KCNQ5 gene encodes Kv7.5, an ion channel implicated in neuronal disorders[1][3], but this is not the same as KCNQ5-DT. Public databases (GeneCards, NCBI, Alliance Genome) describe KCNQ5-DT as an lncRNA with no known molecular function or involvement in clinical therapeutic targeting[4][5]. Summary: KCNQ5-DT is a non-coding RNA gene, not a protein-coding therapeutic target, and has no established function, clinical biomarkers, or drug interactions. There is nothing incorrect about its nomenclature, but it should not be confused with the voltage-gated potassium channel KCNQ5.

Other names
CATG00000088862.1NR_186827.1KCNQ5 divergent transcript
02

Biological functions

Unknown (no published function)
03

Disease associations

Intellectual developmental disorder, autosomal dominant 46 (gene association, not causation)

Beyond the preview

Go deeper on KCNQ5 divergent transcript (KCNQ5-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KCNQ5 divergent transcript (KCNQ5-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call